Click Here for 5% Off Your First Aladdin Purchase!

Uliledlimab (anti-CD73) - Primary antibody, specific to NT5E, >95% (SDS-PAGE&SEC), high purity, Human IgG1

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Cynomolgus monkey,Human
  • Isotype: Human IgG1
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab182937
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab182937-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$79.90
Ab182937-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$399.90
Ab182937-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$669.90
Ab182937-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,099.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameUliledlimab (anti-CD73) - Primary antibody, specific to NT5E, >95% (SDS-PAGE&SEC), high purity, Human IgG1
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityNT5E
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Product Description

Uliledlimab (anti-CD73) is a potent against CD73 humanized monoclonal antibody. Uliledlimab (anti-CD73) inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab (anti-CD73) can be used in research of cancer​.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE26.6 kDa (Light Chain) & 53.7 kDa (Heavy Chain), under reducing conditions; 197.8 kDa, under non-reducing conditions.
Purification MethodProtein A purified
Purity>95% (SDS-PAGE&SEC)
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS2378407-27-1

Images

Uliledlimab (anti-CD73) (Ab182937) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling CD73 (red) with Uliledlimab (anti-CD73) (Ab182937). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Uliledlimab (anti-CD73) (Ab182937) - ELISA
Immobilized human CD73-his tag at 2.0 μg/mL can bind Uliledlimab (anti-CD73) (Ab182937) with the EC50 is 58.13 μg/mL.

Uliledlimab (anti-CD73) (Ab182937) - SEC
The purity of Uliledlimab (anti-CD73) (Ab182937) is more than 95% verified by HPLC.

Associated Targets

NT5E Tchem 5'-nucleotidase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0708130Certificate of AnalysisJul 11, 2024 Ab182937
ZJ24F0708129Certificate of AnalysisJul 11, 2024 Ab182937
ZJ24F0708128Certificate of AnalysisJul 11, 2024 Ab182937

Related Documents

Solution Calculators